Details for Patent: 11,026,901
Which drugs does patent 11,026,901 protect, and when does it expire?
Patent 11,026,901 protects LODOCO and is included in one NDA.
This patent has forty-eight patent family members in twenty-four countries.
Summary for Patent: 11,026,901
| Title: | Treatment or prevention of cardiovascular events via the administration of a colchicine derivative |
| Abstract: | A method for the treatment or prevention of a cardiovascular event in a subject with atherosclerotic vascular disease comprising the step of:b) administering a therapeutically effective amount of a compound of formula (I), a known colchicine derivative and/or a salt thereofwherein:R1, R2, R3, R4, R9, R10, R11 and R12 independently represent hydrogen, C1-4 alkyl, C2-4 alkenyl, C3-6 cycloalkyl, halogen, C1-4 haloalkyl, nitro, amino, C2-4 acylamino, C1-4 alkyl or dialkylamino, hydroxyl, C1-4 alkoxy, C1-4 alkylthio, a group of the formula —SO2N(Rx)2 or SO2Rx where Rx is C1-4 alkyl, C1-4 acyloxy, or optionally substituted phenyl, optionally substituted phenoxy;R7 and R8 independently represent hydrogen, C1-4 alkyl or C1-4 acyl; andR5′, R5″, R6′ and R6″ independently represent hydrogen, C1-4 alkyl, C2-4 alkenyl, C3-6 cycloalkyl, halogen, C1-4 haloalkyl, nitro, amino, C2-4 acylamino, hydroxyl, C1-4 alkoxy or C1-4 alkylthio a group of the formula —SO2N(Rx)2 or SO2Rx where Rx is C1-4 alkyl, C1-4 acyloxy, or optionally substituted phenyl. |
| Inventor(s): | Mark Nidorf |
| Assignee: | Murray and Poole Enterprises Ltd |
| Application Number: | US17/103,683 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Delivery; Dosage form; |
Drugs Protected by US Patent 11,026,901
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Agepha Pharma Fz | LODOCO | colchicine | TABLET;ORAL | 215727-001 | Jun 16, 2023 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | A METHOD FOR TREATING AND/OR REDUCING THE RISK OF ACUTE MYOCARDIAL INFARCTION | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,026,901
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2013337605 | ⤷ Start Trial | |||
| Australia | 2018203715 | ⤷ Start Trial | |||
| Australia | 2019232879 | ⤷ Start Trial | |||
| Australia | 2021282491 | ⤷ Start Trial | |||
| Australia | 2024205084 | ⤷ Start Trial | |||
| Brazil | 112015010063 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
